Page 12 - Transaction Document News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate announcements from Canary Wharf Fin II, Modifications to the T&C's of the Notes

Investegate announcements from Canary Wharf Fin II, Modifications to the T&C's of the Notes

Investegate announcements from Canary Wharf Fin II, Modifications to the T&C's of the Notes

Rule 2.5 Announcement: Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION THIS ANNOUNCEMENT IS BEING MADE PURSUANT TO RULE 2.5 OF THE IRISH TAKEOVER RULES FOR IMMEDIATE RELEASE Transaction Creates Fast-Growing Biopharmaceutical Company with Two Commercial Assets and Robust Clinical Pipe...

Ludgate Funding Plc - Notice of Noteholder Meeting PR Newswire THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF NOTEHOLDERS (AS DEFINED BELOW). If Noteholders are in any doubt about any aspect of the proposals in this notice and/or the action they should take, they are recommended to seek their own financial advice immediately from their stockbroker, bank manager, solicitor, accountant or appropriately authorised independent financial adviser and such other professional advisor from their own professional advisors as they deem necessary. LUDGATE FUNDING PLC (the €19,000,000...